AAAAAA

   
Results: 1-8 |
Results: 8
Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapy
Authors: Ngo-Giang-Huong, N Deveau, C Da Silva, I Pellegrin, I Venet, A Harzic, M Sinet, M Delfraissy, JF Meyer, L Goujard, C Rouzioux, C
Citation: N. Ngo-giang-huong et al., Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapy, AIDS, 15(6), 2001, pp. 665-673
Reduced blood CD123(+) (lymphoid) and CD11c(+) (myeloid) dendritic cell numbers in primary HIV-1 infection
Authors: Pacanowski, J Kahi, S Baillet, M Lebon, P Deveau, C Goujard, C Meyer, L Oksenhendler, E Sinet, M Hosmalin, A
Citation: J. Pacanowski et al., Reduced blood CD123(+) (lymphoid) and CD11c(+) (myeloid) dendritic cell numbers in primary HIV-1 infection, BLOOD, 98(10), 2001, pp. 3016-3021
Frequency of cytokine-producing T cells in HIV-infected patients treated with stavudine, didanosine, and ritonavir
Authors: Levacher, M Bouscarat, F Landman, R Chau, F Damond, F Gaudebout, C Mathez, D Leibowitch, J Saimot, AG Sinet, M
Citation: M. Levacher et al., Frequency of cytokine-producing T cells in HIV-infected patients treated with stavudine, didanosine, and ritonavir, AIDS RES H, 16(17), 2000, pp. 1869-1875
Prospective study of CD8(+) lymphocyte activation in relation to viral load in HIV-infected patients with >= 400 CD4(+) lymphocytes per microliter
Authors: Bouscarat, F Levacher, M Dazza, MC Chau, F Desforges, B Muffat-Joly, M Matheron, S Girard, PM Sinet, M
Citation: F. Bouscarat et al., Prospective study of CD8(+) lymphocyte activation in relation to viral load in HIV-infected patients with >= 400 CD4(+) lymphocytes per microliter, AIDS RES H, 15(16), 1999, pp. 1419-1425
Broad, intense anti-human immunodeficiency virus (HIV) ex vivo CD8(+) responses in HIV type 1-infected patients: Comparison with anti-Epstein-Barr virus responses and changes during antiretroviral therapy
Authors: Dalod, M Dupuis, M Deschemin, JC Sicard, D Salmon, D Delfraissy, JF Venet, A Sinet, M Guillet, JG
Citation: M. Dalod et al., Broad, intense anti-human immunodeficiency virus (HIV) ex vivo CD8(+) responses in HIV type 1-infected patients: Comparison with anti-Epstein-Barr virus responses and changes during antiretroviral therapy, J VIROLOGY, 73(9), 1999, pp. 7108-7116
Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection
Authors: Dalod, M Dupuis, M Deschemin, JG Goujard, C Deveau, C Meyer, L Ngo, N Rouzioux, C Guillet, JG Delfraissy, JF Sinet, M Venet, A
Citation: M. Dalod et al., Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection, J CLIN INV, 104(10), 1999, pp. 1431-1439
Altered ex vivo balance between CD28(+) and CB28(-) cells within HIV-specific CD8(+) T cells of HIV-seropositive patients
Authors: Dalod, M Sinet, M Deschemin, JC Fiorentino, S Venet, A Guillet, JG
Citation: M. Dalod et al., Altered ex vivo balance between CD28(+) and CB28(-) cells within HIV-specific CD8(+) T cells of HIV-seropositive patients, EUR J IMMUN, 29(1), 1999, pp. 38-44
The Th1 to Th2 shift induced by Schistosoma mansoni does not exacerbate murine aids (MAIDS)
Authors: Lacroix, C Akarid, K Chau, F Sinet, M Verola, O Carbon, C Derouin, F
Citation: C. Lacroix et al., The Th1 to Th2 shift induced by Schistosoma mansoni does not exacerbate murine aids (MAIDS), PARASITE IM, 20(10), 1998, pp. 497-501
Risultati: 1-8 |